Jun 3, 2026, 10:00 by Silke Artner

Young innovators from around the world gathered in Innsbruck for IDEASforEARS 2026, where creativity, collaboration, and AI-powered technology by MED‑EL and Microsoft came together to inspire inclusive solutions for hearing loss and turn bright ideas into real-world impact.

May 26, 2026, 10:25 by Silke Artner

MED-EL has acquired two gene therapy programs from Rescue Hearing Inc. targeting MYO7A- and STRC-related genetic causes of balance and hearing disorders, expanding its portfolio with complementary gene-based approaches alongside its existing hearing solutions.

May 20, 2026, 09:01 by Silke Artner

MED‑EL introduces “Milo, the Little Pirate with BONEBRIDGE,” an illustrated storybook that helps children and families understand microtia, atresia, and hearing solutions through engaging, child‑friendly storytelling.

May 11, 2026, 16:00 by Silke Artner

OTOGUIDE is MED‑EL’s new intraoperative tool that provides surgeons with real‑time visualization and feedback during cochlear implant electrode insertion, debuting at CI2026 in Warsaw.

May 7, 2026, 10:43 by Silke Artner

Dr. Ingeborg Hochmair, co‑founder of MED‑EL, received an Honorary Doctor of Engineering from the University of Michigan and inspired graduates as the 2026 Rackham keynote speaker.

Apr 29, 2026, 09:30 by Silke Artner

On Noise Awareness Day 2026, MED‑EL draws attention to the hidden dangers of everyday noise and calls on people worldwide to protect their hearing through awareness, prevention, and early checks.

Apr 15, 2026, 11:00 by Silke Artner

Single-Sided Deafness alters brain and daily function, but cochlear implants restore binaural hearing.

Mar 17, 2026, 09:01 by Silke Artner

Jennifer Robinson shows parents how MED‑EL’s evidence‑based approach simplifies a complex cochlear‑implant decision and focuses on what genuinely supports a child’s future.

Mar 3, 2026, 09:01 by Silke Artner

On World Hearing Day 2026, MED‑EL highlights its year‑round commitment to early hearing care for every child through family support, community networks, and global awareness initiatives.

Feb 25, 2026, 09:30 by Silke Artner

The new Hearpeers Community from MED‑EL gives hearing implant users and candidates a safe global space to connect, share experiences, and support each other.

Feb 12, 2026, 09:01 by Silke Artner

MED‑EL celebrates the nine winners of the 2026 IDEASforEARS contest, where 302 children from 25 countries proved that big ideas for the future of hearing technology can come from the world’s youngest minds.

Feb 12, 2026, 08:00 by Silke Artner

Choosing a cochlear implant is a once‑in‑a‑lifetime decision that shapes how a child will hear, learn, and engage with the world – and MED‑EL supports families with technology, research, and peer guidance to help children thrive.

Feb 11, 2026, 08:32 by Silke Artner

MED‑EL introduces new rechargeable battery options for the SONNET 3 audio processor, delivering up to 23 hours of hearing time in a compact, user‑focused, and backwards‑compatible design.

Feb 3, 2026, 20:30 by Silke Artner

MED‑EL founders and cochlear implant pioneers Ingeborg and Erwin Hochmair have been awarded the 2026 Queen Elizabeth Prize for Engineering, recognising decades of groundbreaking innovation that transformed cochlear implants and restored hearing to millions worldwide.

Jan 1, 2026, 08:00 by MED-EL Elektromedizinische Geräte Gesellschaft m.b.H.

Ingeborg Hochmair is the CEO of MED-EL, an industry leader in implantable hearing solutions. She co-founded the company with her husband, Erwin Hochmair, and they hired their first employees in 1990. Today, the company is still privately run, with its global headquarters located in Innsbruck, Austria.

Dec 16, 2025, 08:00 by MED-EL Elektromedizinische Geräte Gesellschaft m.b.H.

MED-EL, headquartered in Innsbruck, Austria, is a leading provider of hearing implant systems. The privately-owned business was founded by Ingeborg and Erwin Hochmair in the 1980s. Today, MED-EL offers the widest range of implantable and non-implantable solutions for various types and degrees of hearing loss.

Dec 4, 2025, 13:17 by Silke Artner

MED-EL is now the first to offer an FDA-approved cochlear implant in the USA for children as young as seven months, enabling earlier access to hearing and speech development.

Nov 17, 2025, 10:00 by Silke Artner

On World Prematurity Day, MED-EL highlights the heightened risk of hearing loss in preterm infants and the importance of early, tailored interventions – including cochlear implants – to protect their auditory development.

Nov 12, 2025, 10:00 by Silke Artner

MED-EL's IDEASforEARS 2026 Contest invites kids aged 6–12 to invent bold solutions for hearing loss – proving that innovation starts with imagination.

Oct 18, 2025, 10:00 by Silke Artner

Dr. Ingeborg Hochmair and Prof. Erwin Hochmair, founders of MED-EL, received the Horst Scheunemann Medal for their groundbreaking work in cochlear implant technology and interdisciplinary contributions to skull base surgery.

Jun 3, 2026, 10:00 by Silke Artner

Young innovators from around the world gathered in Innsbruck for IDEASforEARS 2026, where creativity, collaboration, and AI-powered technology by MED‑EL and Microsoft came together to inspire inclusive solutions for hearing loss and turn bright ideas into real-world impact.

May 26, 2026, 10:25 by Silke Artner

MED-EL has acquired two gene therapy programs from Rescue Hearing Inc. targeting MYO7A- and STRC-related genetic causes of balance and hearing disorders, expanding its portfolio with complementary gene-based approaches alongside its existing hearing solutions.

May 20, 2026, 09:01 by Silke Artner

MED‑EL introduces “Milo, the Little Pirate with BONEBRIDGE,” an illustrated storybook that helps children and families understand microtia, atresia, and hearing solutions through engaging, child‑friendly storytelling.

May 11, 2026, 16:00 by Silke Artner

OTOGUIDE is MED‑EL’s new intraoperative tool that provides surgeons with real‑time visualization and feedback during cochlear implant electrode insertion, debuting at CI2026 in Warsaw.

May 7, 2026, 10:43 by Silke Artner

Dr. Ingeborg Hochmair, co‑founder of MED‑EL, received an Honorary Doctor of Engineering from the University of Michigan and inspired graduates as the 2026 Rackham keynote speaker.

Apr 29, 2026, 09:30 by Silke Artner

On Noise Awareness Day 2026, MED‑EL draws attention to the hidden dangers of everyday noise and calls on people worldwide to protect their hearing through awareness, prevention, and early checks.

Apr 15, 2026, 11:00 by Silke Artner

Single-Sided Deafness alters brain and daily function, but cochlear implants restore binaural hearing.

Mar 17, 2026, 09:01 by Silke Artner

Jennifer Robinson shows parents how MED‑EL’s evidence‑based approach simplifies a complex cochlear‑implant decision and focuses on what genuinely supports a child’s future.

Mar 3, 2026, 09:01 by Silke Artner

On World Hearing Day 2026, MED‑EL highlights its year‑round commitment to early hearing care for every child through family support, community networks, and global awareness initiatives.

Feb 25, 2026, 09:30 by Silke Artner

The new Hearpeers Community from MED‑EL gives hearing implant users and candidates a safe global space to connect, share experiences, and support each other.

Feb 12, 2026, 09:01 by Silke Artner

MED‑EL celebrates the nine winners of the 2026 IDEASforEARS contest, where 302 children from 25 countries proved that big ideas for the future of hearing technology can come from the world’s youngest minds.

Feb 12, 2026, 08:00 by Silke Artner

Choosing a cochlear implant is a once‑in‑a‑lifetime decision that shapes how a child will hear, learn, and engage with the world – and MED‑EL supports families with technology, research, and peer guidance to help children thrive.

Feb 11, 2026, 08:32 by Silke Artner

MED‑EL introduces new rechargeable battery options for the SONNET 3 audio processor, delivering up to 23 hours of hearing time in a compact, user‑focused, and backwards‑compatible design.

Feb 3, 2026, 20:30 by Silke Artner

MED‑EL founders and cochlear implant pioneers Ingeborg and Erwin Hochmair have been awarded the 2026 Queen Elizabeth Prize for Engineering, recognising decades of groundbreaking innovation that transformed cochlear implants and restored hearing to millions worldwide.

Jan 1, 2026, 08:00 by MED-EL Elektromedizinische Geräte Gesellschaft m.b.H.

Ingeborg Hochmair is the CEO of MED-EL, an industry leader in implantable hearing solutions. She co-founded the company with her husband, Erwin Hochmair, and they hired their first employees in 1990. Today, the company is still privately run, with its global headquarters located in Innsbruck, Austria.

Dec 16, 2025, 08:00 by MED-EL Elektromedizinische Geräte Gesellschaft m.b.H.

MED-EL, headquartered in Innsbruck, Austria, is a leading provider of hearing implant systems. The privately-owned business was founded by Ingeborg and Erwin Hochmair in the 1980s. Today, MED-EL offers the widest range of implantable and non-implantable solutions for various types and degrees of hearing loss.

Dec 4, 2025, 13:17 by Silke Artner

MED-EL is now the first to offer an FDA-approved cochlear implant in the USA for children as young as seven months, enabling earlier access to hearing and speech development.

Nov 17, 2025, 10:00 by Silke Artner

On World Prematurity Day, MED-EL highlights the heightened risk of hearing loss in preterm infants and the importance of early, tailored interventions – including cochlear implants – to protect their auditory development.

Nov 12, 2025, 10:00 by Silke Artner

MED-EL's IDEASforEARS 2026 Contest invites kids aged 6–12 to invent bold solutions for hearing loss – proving that innovation starts with imagination.

Oct 18, 2025, 10:00 by Silke Artner

Dr. Ingeborg Hochmair and Prof. Erwin Hochmair, founders of MED-EL, received the Horst Scheunemann Medal for their groundbreaking work in cochlear implant technology and interdisciplinary contributions to skull base surgery.